We are live on
!
Find out more
BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
1-Year Est. Return
51.97%
This Fund
S&P 500
This Quarter
Est. Return
+21.82%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
–
AUM
$1.43B
AUM Growth
-$15.1M
(-1%)
Cap. Flow
-$151M
Cap. Flow
% of AUM
-10.53%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
453
New
131
Increased
60
Reduced
89
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$14M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$13.1M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$12.7M |
| 4 |
TIM SA
TIMB
|
+$12.4M |
| 5 |
Louisiana-Pacific
LPX
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$16.5M |
| 2 |
HOUS
Anywhere Real Estate
HOUS
|
+$15.3M |
| 3 |
MRC
MRC Global
MRC
|
+$15.3M |
| 4 |
Lumentum
LITE
|
+$13.7M |
| 5 |
Ryanair
RYAAY
|
+$13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.18% |
| 2 | Technology | 16.96% |
| 3 | Consumer Discretionary | 15.32% |
| 4 | Industrials | 9.89% |
| 5 | Materials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$209B
| $13.4M | 0.94% |
81,828
| – | – |
|
|
TMHC
27
DELISTED
Taylor Morrison
TMHC
| $13.3M | 0.92% |
622,014
+601,271
| +2,899% | +$12.1M |
|
|
28
TIM SA
TIMB
$9.1B
| $13.2M | 0.92% |
+823,957
| New | +$12.4M |
|
|
PTLA
29
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $12.9M | 0.9% |
+330,318
| New | +$10.5M |
|
|
UNVR
30
DELISTED
Univar Solutions Inc.
UNVR
| $12.9M | 0.9% |
+421,305
| New | +$12.7M |
|
|
HTZ
31
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $12.9M | 0.9% |
845,179
+150,565
| +22% | +$2.73M |
|
32
STMicroelectronics
STM
$43.1B
| $12.6M | 0.88% |
816,959
-348,242
| -30% | -$4.85M |
|
|
TSE
33
DELISTED
Trinseo
TSE
| $12.6M | 0.88% |
187,940
+157,345
| +514% | +$10.6M |
|
34
Cirrus Logic
CRUS
$6.76B
| $12.6M | 0.88% |
207,069
-57,202
| -22% | -$3.26M |
|
35
Idexx Laboratories
IDXX
$44.9B
| $12.5M | 0.87% |
+81,132
| New | +$11.2M |
|
|
ENDP
36
DELISTED
Endo International plc
ENDP
| $12.5M | 0.87% |
1,117,897
+346,928
| +45% | +$4.31M |
|
37
NVR
NVR
$17.1B
| $12.4M | 0.87% |
+5,900
| New | +$11.2M |
|
|
MOMO
38
Hello Group
MOMO
$867M
| $12.4M | 0.86% |
+363,693
| New | +$9.7M |
|
39
NCR Voyix
VYX
$1.19B
| $12.3M | 0.86% |
438,317
-116,923
| -21% | -$3.2M |
|
|
NTRI
40
DELISTED
NutriSystem, Inc.
NTRI
| $12.3M | 0.86% |
221,106
+157,818
| +249% | +$6.52M |
|
41
Xerox
XRX
$345M
| $12.2M | 0.85% |
+417,133
| New | +$12M |
|
|
CELG
42
DELISTED
Celgene Corp
CELG
| $12.2M | 0.85% |
98,392
+4,500
| +5% | +$539K |
|
|
BRSL
43
Brightstar Lottery PLC
BRSL
$1.9B
| $12.2M | 0.85% |
516,327
| – | – |
|
44
Elevance Health
ELV
$81.5B
| $12.1M | 0.85% |
+73,412
| New | +$11.7M |
|
45
Lamb Weston
LW
$7.42B
| $12M | 0.84% |
+285,013
| New | +$11.2M |
|
46
CDW
CDW
$18.9B
| $11.8M | 0.82% |
204,441
+198,226
| +3,189% | +$11.2M |
|
47
Seagate
STX
$173B
| $11.8M | 0.82% |
+256,355
| New | +$11.4M |
|
|
PIR
48
DELISTED
Pier 1 Imports, Inc.
PIR
| $11.7M | 0.82% |
81,953
+10,043
| +14% | +$1.47M |
|
49
DaVita
DVA
$15.5B
| $11.7M | 0.82% |
+172,107
| New | +$11.4M |
|
|
KATE
50
DELISTED
Kate Spade & Company
KATE
| $11.6M | 0.81% |
+500,252
| New | +$10.5M |
|
Similar funds
FC
NISOA
UMA
HS
DFG
SRCM
OFM
SAM
Bogle Investment Management's Q1 2017 Portfolio in Review
As of Q1 2017, Bogle Investment Management held 453 positions worth $1.43B, down 1% from $1.45B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bogle Investment Management withdrew a net $151M in Q1 2017, closing 160 positions and reducing 89 holdings. Its most notable exit was Applied Materials, an estimated $16.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bogle Investment Management opened a new position in Bausch Health worth $11.2M.
- Bogle Investment Management's largest Q1 2017 buy was Bausch Health: 1,017,557 shares worth $11.2M.
- Bogle Investment Management added most to Taylor Morrison in Q1 2017, an estimated $12.1M increase.
- Bogle Investment Management's biggest Q1 2017 reduction was ODP, cutting an estimated $12M.
- Bogle Investment Management fully exited Applied Materials in Q1 2017, selling an estimated $16.5M.
- Bogle Investment Management's ten largest holdings make up 13% of its $1.43B portfolio in Q1 2017.
- Bogle Investment Management opened 131 new positions and closed 160 in Q1 2017.
- Bogle Investment Management's portfolio value fell 1% quarter-over-quarter to $1.43B.
Based on Bogle Investment Management's 13F filing for Q1 2017, filed 12 May 2017.